NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for GENEVANT SCIENCES, INC. · Business/legal/admin.for tech-focused nucleic acid development and delivery company

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Jul 17, 2025

Lobbying activity 1

Health Issues

Healthcare matters

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.